Identification of a novel peptide ligand of human transfrrin receptor 1 for targeted tumor delivery drug

Protein and Peptide Letters

Volumn 20, Issue 1, 2013, Pages 96-101

  Qin, Xin ^a   Cun, Zhang ^a   Xue, Xiaochang ^a   Li, Meng ^a   Li, Weina ^a   Hao, Qiang ^a   Zhang, Yingqi ^a   Zhen, Yan ^a   Wei, Zhang ^a  

^a State Key Laboratory of Cancer Biology   (China)

Author keywords

Peptide; Phage display; TfR1

Indexed keywords

CD71 ANTIGEN; PEPTIDE; PEPTIDE B 18; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CARCINOMA CELL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PEPTIDE LIBRARY; PHAGE DISPLAY; PROTEIN ANALYSIS; PROTEIN BINDING;

EID: 84872898342     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986613804096838     Document Type: Article

References (20)

1. Qian, Z.M.; Li, H.; Sun, H.; Ho, K. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol. Res., 2002, 54, 561-587
2. Reubi, J.C. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocrine Rev., 2003, 24, 389-427
3. Wagner, Jr H.N. Nuclear medicine: 100 years in the making. J. Nucl. Med., 1996, 37(10), 18N, 24N, 37N
4. Jing, S.Q.; Trowbridge, I.S. Identification of intermolecular disulfide bonds of the human transferrin receptor and its lipidattachment site. EMBO, 1987, 6, 327-331
5. Yang, D.C.; Wang, F.; Elliott, R.L.; Head, J.F. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer. Anticancer Res., 2001, 21, 541-549.
6. Prior, R.; Reifenberger, G.; Wechsler, W. Transferrin receptor expression in tumours of the human nervous system: Relation to tumour type, grading and tumour growth fraction. Virchows Arch. A Pathol. Anat. Histopathol., 1990, 416, 491-496.
7. Das, G.A.; Shah, V.I. Correlation of transferrin receptor expression with histologic grade and immunophenotype in chronic lymphocytic leukemia and non-Hodgkin's lymphoma. Hematol. Pathol., 1990, 4, 37-41.
8. Habeshaw, J.A.; Lister, T.A.; Stansfeld, A.G.; Greaves, M.F. Correlation of transferrin receptor expression with histological class and outcome in non-Hodgkin lymphoma. Lancet, 1983, 1, 498-501.
9. Kondo, K.; Noguchi, M.; Mukai, K.; Matsuno, Y.; Sato, Y.; Shimosato, Y.; Monden, Y. Transferrin receptor expression in adenocarcinoma of the lung as a histopathologic indicator of prognosis. Chest, 1990, 97, 1367-1371.
10. Seymour, G.J.; Walsh, M.D.; Lavin, M.F.; Strutton, G.; Gardiner, R.A. Transferrin receptor expression by human bladder transitional cell carcinomas. Urol. Res., 1987, 15, 341-344.
11. Kawamoto, M.; Horibe, T.; Kohno, M.; Kawakami, K. A novel transferrin receptor-targeted hybrid peptide disintegrates cancer cell membrane to induce rapid killing of cancer cells. BMC Cancer, 2011, 11, 359.
12. Xia, H.; Anderson, B.; Mao, Q.; Davidson, B.L. Recombinant human adenovirus: Targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium. J. Virol., 2000, 74, 11359-66.
13. Daniels, T.R.; Bernabeu, E.; Rodríguez, J.A.; Patel, S.; Kozman, M.; Chiappetta, D.A.; Holler, E.; Ljubimova, J.Y.; Helguera, G.; Penichet, M.L. The transferrin receptor and the targeted delivery of therapeutic agents against cancer. Biochim. Biophys. Acta, 2012, 1820, 291-317.
14. Chen, Y.P.; Shen, Y.; Guo, X.; Zhang, C.; Yang, W.; Ma, M.; Liu, S.; Zhang, M.; Wen, L.P. Transdermal protein delivery by a coadministered peptide identi?ed via phage display. Nat. Biotechnol., 2006, 24, 455-60.
15. Meng, J.R.; Ma, N.; Yan, Z.; Han, W.; Zhang, Y. NGR Enhanced the Anti-Angiogenic Activity of tum-5. J. Biochem., 2006, 140, 1-6
16. Sacchi, A.; Gasparri, A.; Curnis, F.; Bellone, M.; Corti, A. Crucial role for interferon ? in the synergism between tumor vasculaturetargeted tumor necrosis factor ? (NGR-TNF) and doxorubicin. Cancer Res., 2004, 64, 7150-7155
17. Singh, M.; Atwal, H.; Micetich, R. Transferrin directed delivery of adriamycin to human cells. Anticancer Res., 1998, 18, 1423-1427.
18. Lai, B.T.; Gao, J.P.; Lanks, K.W. Mechanism of action and spectrum of cell lines sensitive to a doxorubicin-transferrin conjugate. Cancer Chemother. Pharmacol., 1998, 41, 155-160.
19. Pirker, R.; FitzGerald, D.J.; Hamilton, T.C.; Ozols, R.F.; Willingham, M.C.; Pastan, I. Anti-transferrin receptor antibody linked to Pseudomonas exotoxin as a model immunotoxin in human ovarian carcinoma cell lines. Cancer Res., 1985, 45, 751-757.
20. Ye, Q.; Wang, S.; Wang, Z.H.; Zhu, H.F.; Lei, P.; Liu, L.J.; Zhao, X.R.; Chao, L.M.; Xiao, D.W.; Huang, Y.; Xing, W.; Fang, M.; Feng, Z.H.; Shen, G.X. Cancer Immunol. Immunother., 2006, 55, 1111-21.